Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes.

Transgenic mice (K5-PKC alpha) in which the keratin 5 promoter directs the expression of protein kinase C-alpha (PKC alpha) to epidermal keratinocytes display a 10-fold increase in PKC alpha protein in their epidermis and alterations in phorbol ester-induced cutaneous inflammation [J Cell Science 1999;112:3497-3506]. In the current study, we have used these K5-PKC alpha mice to examine the role of PKC alpha in keratinocyte phospholipid metabolism/eicosanoid production and cutaneous inflammation. Primary keratinocytes from wild-type and transgenic mice were prelabeled in culture with [(3)H]arachidonic acid (AA) and subsequently treated with TPA. Compared with wild-type keratinocytes, K5-PKC alpha keratinocytes displayed a 2-fold increase in AA release. TPA treatment resulted in the phosphorylation of cPLA(2). PKC inhibitors GF-109203X or H7, but not mitogen-activated protein/extracellular signal-regulated protein kinase (MEK) inhibitor PD 98059, could inhibit phosphorylation and AA release. Topical 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment of K5-PKC alpha mice resulted in a 5-fold increase in epidermal COX-2 induction and a 2- to 3-fold increase in prostaglandin (PG) E(2) levels above that observed in TPA-treated wild-type mice. PD 98059, GF-109203X, or H7 could block cyclooxygenase-2 (COX-2) induction by TPA. Because C/EBP beta, a basic leucine zipper transcription factor, can be activated via a PKC alpha/mitogen-activated protein kinase pathway and can influence COX-2 expression, we examined whether C/EBP beta is involved in TPA-induced epidermal COX-2 expression. TPA-induced COX-2 expression was similar in C/EBP beta nullizygous and wild-type mice. In summary, our results indicate that epidermal PKC alpha coordinately regulates cPLA(2) activity and COX-2 expression resulting in increased levels of AA and PGE(2). Furthermore, PKC alpha-induced AA release and cPLA(2) phosphorylation are independent of MEK, whereas PKC alpha-induced COX-2 expression and PGE(2) production are MEK-dependent and C/EBP beta-independent events.

[1]  C. Yuan,et al.  Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. , 2000, Cancer research.

[2]  S. Reddy,et al.  Transcriptional Regulation of the Cyclooxygenase-2 Gene in Activated Mast Cells* , 2000, The Journal of Biological Chemistry.

[3]  J. Zou,et al.  Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. , 2000, Cancer research.

[4]  M. Gelb,et al.  Stress stimuli increase calcium-induced arachidonic acid release through phosphorylation of cytosolic phospholipase A2. , 1999, The Biochemical journal.

[5]  C. Tseng,et al.  Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. , 1999, Cancer research.

[6]  R. Smart,et al.  Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion. , 1999, Journal of cell science.

[7]  K. Subbaramaiah,et al.  Regulation of Cyclooxygenase-2 by Interferon γ and Transforming Growth Factor α in Normal Human Epidermal Keratinocytes and Squamous Carcinoma Cells , 1999, The Journal of Biological Chemistry.

[8]  P. Cohen,et al.  Phosphorylation of cytosolic phospholipase A2 in platelets is mediated by multiple stress-activated protein kinase pathways. , 1999, European journal of biochemistry.

[9]  R. Langenbach,et al.  Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. , 1999, Biochemical pharmacology.

[10]  G. FitzGerald,et al.  Arachidonic Acid in Platelet Microparticles Up-regulates Cyclooxygenase-2-dependent Prostaglandin Formation via a Protein Kinase C/Mitogen-activated Protein Kinase-dependent Pathway* , 1999, The Journal of Biological Chemistry.

[11]  K. Subbaramaiah,et al.  Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. , 1999, The Journal of biological chemistry.

[12]  S. Fischer,et al.  Transcriptional Regulation of Cyclooxygenase-2 in Mouse Skin Carcinoma Cells , 1998, The Journal of Biological Chemistry.

[13]  S. Fischer,et al.  Suppression or elevation of cytosolic phospholipase A2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis. , 1998, Cancer research.

[14]  R. Smart,et al.  Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. , 1998, The Journal of investigative dermatology.

[15]  S. Husain,et al.  Role of protein kinase C α in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells , 1998 .

[16]  J. Masferrer,et al.  COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. , 1998, Carcinogenesis.

[17]  T. Tanabe,et al.  Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. , 1998, Biochemical and biophysical research communications.

[18]  S. Husain,et al.  Role of protein kinase C alpha in endothelin-1 stimulation of cytosolic phospholipase A2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells. , 1998, Biochimica et biophysica acta.

[19]  L. Tessarollo,et al.  An essential role for C/EBPbeta in female reproduction. , 1997, Genes & development.

[20]  K. Subbaramaiah,et al.  Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. , 1997, Cancer research.

[21]  L. Crofford,et al.  COX-1 and COX-2 tissue expression: implications and predictions. , 1997, The Journal of rheumatology. Supplement.

[22]  S. Watson,et al.  Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. , 1997, European journal of biochemistry.

[23]  H. Herschman,et al.  Transcriptional Regulation of Prostaglandin Synthase 2 Gene Expression by Platelet-derived Growth Factor and Serum* , 1996, The Journal of Biological Chemistry.

[24]  S. Fischer,et al.  Multifactor regulation of prostaglandin H synthase‐2 in murine keratinocytes , 1996, Molecular carcinogenesis.

[25]  J. Adams,et al.  Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils. , 1996, The Biochemical journal.

[26]  T. Eling,et al.  Prostaglandin synthase 2 expression in epidermal growth factor-dependent proliferation of mouse keratinocytes. , 1996, Archives of biochemistry and biophysics.

[27]  I. Taylor,et al.  Cloning and Expression of Cytosolic Phospholipase A2 (cPLA2) and a Naturally Occurring Variant , 1996 .

[28]  P. Insel,et al.  Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells. , 1996, The Journal of clinical investigation.

[29]  H. Nakata,et al.  alpha-1-Adrenergic receptor stimulation causes arachidonic acid release through pertussis toxin-sensitive GTP-binding protein and JNK activation in rabbit aortic smooth muscle cells. , 1996, Biochemical and biophysical research communications.

[30]  I. Taylor,et al.  Cloning and expression of cystolic phospholipase A2 (cPLA2) and a naturally occurring variant. Phosphorylation of Ser505 of recombinant cPLA2 by p42 mitogen-activated protein kinase results in an increase in specific activity. , 1996, European journal of biochemistry.

[31]  D. Dewitt,et al.  Prostaglandin endoperoxide H synthases-1 and -2. , 1996, Advances in immunology.

[32]  Kei Yamamoto,et al.  Transcriptional Roles of Nuclear Factor B and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor -Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.

[33]  William L. Smith,et al.  Calcium-mediated Translocation of Cytosolic Phospholipase A2 to the Nuclear Envelope and Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.

[34]  H. Herschman,et al.  v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.

[35]  E. Chi,et al.  Translocation of the 85-kDa Phospholipase A2 from Cytosol to the Nuclear Envelope in Rat Basophilic Leukemia Cells Stimulated with Calcium Ionophore or IgE/Antigen (*) , 1995, The Journal of Biological Chemistry.

[36]  T. Molski,et al.  Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. , 1995, The Biochemical journal.

[37]  R. Sha’afi,et al.  A Mitogen-Activated Protein Kinase-Independent Pathway Involved in the Phosphorylation and Activation of Cytosolic Phospholipase A2 in Human Neutrophils Stimulated with Tumor Necrosis Factor-α , 1995 .

[38]  R. Sha’afi,et al.  A mitogen-activated protein kinase independent pathway involved in the phosphorylation and activation of cytosolic phospholipase A2 in human neutrophils stimulated with tumor necrosis factor-alpha. , 1995, Biochemical and biophysical research communications.

[39]  N. Ueda,et al.  Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. , 1995, The Journal of biological chemistry.

[40]  A. Ristimäki,et al.  Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. , 1994, The Journal of biological chemistry.

[41]  C. Trautwein,et al.  Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain , 1993, Nature.

[42]  Walter Kolch,et al.  Protein kinase Cα activates RAF-1 by direct phosphorylation , 1993, Nature.

[43]  P. Insel,et al.  Inhibition of expression of protein kinase C alpha by antisense cDNA inhibits phorbol ester-mediated arachidonate release. , 1993, The Journal of biological chemistry.

[44]  F. Totzke,et al.  Over‐expression of protein kinase C‐α enhances platelet‐derived growth factor‐ and phorbol ester‐ but not calcium ionophore‐induced formation of prostaglandins in NIH 3T3 fibroblasts , 1993, FEBS letters.

[45]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[46]  Roger J. Davis,et al.  cPLA2 is phosphorylated and activated by MAP kinase , 1993, Cell.

[47]  G L Johnson,et al.  Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. , 1993, The Journal of biological chemistry.

[48]  W. Kolch,et al.  Protein kinase C alpha activates RAF-1 by direct phosphorylation. , 1993, Nature.

[49]  G. De Nucci.  Eicosanoids and skin. , 1988, Biochemical Society transactions.

[50]  R. Irvine.  How is the level of free arachidonic acid controlled in mammalian cells? , 1982, The Biochemical journal.

[51]  P. Alexander.  Prostaglandins and cancer , 1982, Nature.